Exclusive

Publication

Byline

US Patent Issued to NAJRAN UNIVERSITY on June 2 for "Method for producing a core-shell capsule for delivering a therapeutic agent" (Saudi Arabia Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,774, issued on June 2, was assigned to NAJRAN UNIVERSITY (Najran, Saudi Arabia). "Method for producing a core-shell capsule for delivering a... Read More


US Patent Issued to Philip Morris Products on June 2 for "Substrate for delivering a biologically active substance" (Armenian, French Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,775, issued on June 2, was assigned to Philip Morris Products S.A. (Neuchatel, Switzerland). "Substrate for delivering a biologically active... Read More


US Patent Issued to CJ CHEILJEDANG on June 2 for "Anticoccidial composition comprising stilbene-based compound, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,776, issued on June 2, was assigned to CJ CHEILJEDANG Corp. (Seoul, South Korea). "Anticoccidial composition comprising stilbene-based compo... Read More


US Patent Issued to SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL, SHENZHEN CHINA RESOURCES GOSUN PHARMACEUTICALS on June 2 for "Use of mitoxantrone preparation in preparation of drug for diagnosing and treating breast cancer" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,777, issued on June 2, was assigned to SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL Co. LTD (Shenzhen, China) and SHENZHEN C... Read More


US Patent Issued to CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) on June 2 for "Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,778, issued on June 2, was assigned to CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd (Shijiazhuang, China). "Use of mitoxant... Read More


US Patent Issued to Amphastar Pharmaceuticals on June 2 for "Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,779, issued on June 2, was assigned to Amphastar Pharmaceuticals Inc. (Rancho Cucamonga, Calif.). "Albuterol aerosol suspension formulation ... Read More


US Patent Issued to The Regents of the University of California on June 2 for "Methods and compositions to treat and prevent viral infections and acute respiratory distress syndrome" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,780, issued on June 2, was assigned to The Regents of the University of California (Oakland, Calif.). "Methods and compositions to treat and... Read More


US Patent Issued on June 2 for "Adenomyosis associated infertility and hdac inhibitors" (Bulgarian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,781, issued on June 2. "Adenomyosis associated infertility and hdac inhibitors" was invented by Gueorgui Stamenov (Sofia, Bulgaria) and Mari... Read More


US Patent Issued on June 2 for "Ketogenic compositions and methods of use thereof" (Canadian Inventor)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,782, issued on June 2. "Ketogenic compositions and methods of use thereof" was invented by Franco Cavaleri (Surrey, Canada). According to t... Read More


US Patent Issued to NICOX, FERA PHARMACEUTICALS on June 2 for "Method for treating vaso occlusive crises associated with Sickle cell disease" (American, French Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,783, issued on June 2, was assigned to NICOX SA (Sophia Antipolis, France) and FERA PHARMACEUTICALS LLC (Locust Valley, N.Y.). "Method for t... Read More